ALM Ortho
ALM Ortho designs and manufactures patient-matched titanium orthopedic implants using electron-beam additive manufacturing.
- Team Size
- 1-10
- Stage
- Growth Stage
- Total Funding
- $1.75M
- Latest Round
- Series A
- Key Investors
- Central Texas Angel Network; Keiretsu Forum; Paul DeJuliis
Technology & Products
Key Products
Patient-matched titanium orthopedic implants, related components, and instrumentation for limb reconstruction, oncology, trauma, and revision procedures.
Technological Advantage
The company combines surgeon-collaborative CT-based design with GE Additive Arcam Q10plus EBM production in Ti-6Al-4V ELI and a traceable delivery workflow.
Differentiation
Value Proposition
A scan-to-surgery service that turns patient imaging and surgeon direction into bespoke orthopedic devices.
How They Differentiate
ALM Ortho focuses on case-specific titanium implants and integrated design-to-delivery service for complex orthopedic cases rather than a standardized implant catalog.
Market & Competition
Target Customers
Orthopedic surgeons and healthcare facilities treating complex reconstruction, oncology, trauma, revision, and osseointegration cases.
Industry Verticals
Orthopedics; limb reconstruction; oncology; trauma; revision surgery; shoulder reconstruction.
Competitors
restor3d; Zimmer Biomet; Meticuly.
Growth & Milestones
Major Milestones
Founded in 2020; announced a seed round in 2021; raised a $1M Series A round in October 2024; announced an exclusive U.S. upper-extremity partnership with Shoulder Innovations in 2026.
Recent coverage of ALM Ortho
Funding rounds
- Series A$1M2024-10Lead: Central Texas Angel Network · Source